Part I: Overview, Basic Principles and Methodology
Ocular Therapeutics and Drug Delivery: An Overview - Indra K. Reddy, Ph.D., St. John's University, and Madurai G. Ganesan, Ph.D., American Cyanamid Company
Surface Chemical Aspects of Ocular Drug Delivery Systems - C. P. Singh, Ph.D., and Dinesh O. Shah, Ph.D., University of Florida
Biological Barriers to Ocular Drug Delivery - John C. Lang, Ph.D., Alcon Laboratories, Inc., and Monica M. Stiemke, Ph.D., University of Texas Health Science Center at Houston
Pharmacodynamic and Pharmacokinetic Correlations of Ophthalmic Drugs - Diane D.-S. Tang-Liu, Ph.D., and Andrew Acheampong, Ph.D., Allergan Inc.; Du-Shieng Chien, Ph.D., Miles, Inc.; and Joel I. Usansky, Ph.D., Allergan Inc.
Drug Metabolizing Enzyme Systems in the Eye - Gondi N. Kumar, Ph.D., Medical University of South Carolina
Part II: Pathopharmacology and Clinical Applications
Artificial Tear Formulations, Irrigating Solutions and Contact Lens Products - Indra K. Reddy, Ph.D., Wahid Aziz, and Robert B. Sause, Ph.D., R.Ph., St. John's University
Clinical Pharmacology of the Anterior Segment of the Eye - Michael A. Barletta, Ph.D., and Indra K. Reddy, Ph.D., St. John's University
Recent Developments in Anti-Glaucoma Drug Research - Markku Leino, M.D., Ph.D., and Arto Urtti, Ph.D., University of Kuopio, Finland
Vitreoretinal Diseases: Pathological Aspects and Therapeutic Strategies - Gholam A. Peyman, M.D., Louisiana State University
Part III: Chemical/Biochemical Approaches to Ocular Drug Delivery
Prodrugs: A Chemical Approach to Ocular Drug Delivery - Vijay K. Tammara, Ph.D., Food and Drug Administration, and Michael A. Crider, Ph.D., Northeast Louisiana University
The Use of Retrometabolic Drug Design Concepts in Ophthalmic Drug Discovery - Nicholas Bodor, Ph.D., D.Sc., University of Florida
Development of Soft Drugs for Ophthalmic Use - John F. Howes, Ph.D., Pharmos Cor
